Novartis AG
NVS
Company Profile
Business description
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Contact
Lichtstrasse 35
Basel 4056
CHET: +41 613241111
E: investor.relations@novartis.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
76,057
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
---|---|---|---|
All Ordinaries | 8,002.50 | 39.40 | 0.49% |
CAC 40 | 7,805.79 | 58.91 | -0.75% |
DAX 40 | 18,499.36 | 131.50 | -0.71% |
Dow JONES (US) | 38,712.21 | 35.21 | -0.09% |
FTSE 100 | 8,184.54 | 30.94 | -0.38% |
HKSE | 18,112.63 | 174.79 | 0.97% |
NASDAQ | 17,608.44 | 264.89 | 1.53% |
Nikkei 225 | 38,720.47 | 156.24 | -0.40% |
NZX 50 Index | 11,872.64 | 130.76 | 1.11% |
S&P 500 | 5,421.03 | 45.71 | 0.85% |
S&P/ASX 200 | 7,749.70 | 34.20 | 0.44% |
SSE Composite Index | 3,028.92 | 8.55 | -0.28% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
---|---|---|---|
Sigma Healthcare Ltd SIG | 1.16 | 0.05 | -3.73% |
Peninsula Energy Ltd PEN | 0.10 | 0.00 | 4.17% |
South32 Ltd S32 | 3.64 | 0.00 | 0.00% |
Pilbara Minerals Ltd PLS | 3.32 | 0.09 | -2.64% |
Telstra Group Ltd TLS | 3.53 | 0.01 | 0.28% |
Core Lithium Ltd CXO | 0.09 | 0.00 | -1.05% |
Red 5 Ltd RED | 0.44 | 0.01 | 1.15% |
Mirvac Group MGR | 1.93 | 0.03 | 1.58% |
TerraCom Ltd TER | 0.22 | 0.01 | -2.27% |
Imugene Ltd IMU | 0.06 | 0.00 | 1.75% |